摘要
目的 分析重型再生障碍性贫血(SAA)患者免疫抑制治疗(IST)前、后外周血自然杀伤(NK)细胞亚群占淋巴细胞百分比、功能变化及其与造血功能相关性,探讨NK细胞在SAA发病机制中的作用.方法 用流式细胞术检测2010年4月至2010年12月天津医科大学总医院收治的12例初治(初治组)、30例IST后恢复(恢复组)的SAA患者的外周血NK细胞(CD3^-CD56^+/CD16^+)及其亚群[CD3^-CD56^brightCD16^-(CD56^bright)、CD3^-CD56^dimCD16^+(CD56^dim)、CD3^-CD56^-CD16^+]占淋巴细胞百分比、活化性受体(NKG2D和NKp46)、穿孔素、颗粒酶β表达,并与13名健康对照(对照组)比较;分析上述变化与外周血中性粒细胞比例(ANC%)、淋巴细胞比例、网织红细胞计数及骨髓造血功能(增生程度、粒系百分比、红系百分比、巨核细胞数量、淋系百分比)的相关性.结果 (1)初治组NK细胞、CD56^bright细胞百分比(10.30%±6.08%、0.11%)均显著低于恢复组(16.47%±8.29%、0.68%,P<0.05)和对照组(19.45%±6.88%、0.53%,均P<0.05);初治组CD56^dim细胞百分比(9.62%±6.04%)明显低于对照组(18.21%±7.16%,P<0.05);恢复组CD3^-CD56^-CD16^+细胞百分比(0.79%)显著高于初治组及对照组(0.37%、0.41%,均P<0.05).(2)初治组与恢复组NK细胞NKp46、穿孔素表达[初治组(88.23%、64.97%±21.61%),恢复组(82.97%、66.14%±20.73%)]显著高于对照组(40.99%、42.11%±27.25%,均P<0.05).(3)NK、CD56^bright及CD3^-CD56^-CD16^+细胞的百分比与SAA患者ANC%呈正相关(r分别为0.423、0.609、0.468,均P<0.05),与骨髓粒系百分比呈正相关(r分别为0.357、0.517、0.434,均P<0.05);NK、CD56^bright、CD56^dim和CD3^-CD56^-CD16^+细胞的百分比与SAA患者骨髓增生程度呈正相关(r分别为0.455、0.412、0.404、0.451,均P<0.05),与骨髓淋系百分比呈负相关(r分别为-0.522、-0.435、-0.411、-0.547,均P<0.05);NK细胞NKG2D、NKp46、穿孔素、颗粒酶β表达与各造血指标无相关性(均P>0.05).结论 SAA患者外周血NK细胞、CD56^bright、CD56^dim亚群占淋巴细胞百分比降低及穿孔素途径增强可能引起免疫耐受被破坏、T细胞功能亢进而导致造血功能衰竭.
Objective To analyze the percentage and functional changes of natural killer(NK)cell subsets in peripheral blood of severe aplastic anemia(SAA)patients before and after immunosuppressive therapy(IST)so as to evaluate the relationships between these changes and hematopoietic functions and explore the role of NK cells in the pathogenesis of SAA.Methods By flow cytometry,the percentages of NK cells(CD3^-CD56+/CD16^+)and its subsets[CD3^-CD56^brightCD16-(CD56^bright),CD3^-CD56^dimCD16^+(CD56^dim),CD3^-CD56^-CD16^+]in peripheral blood lymphocytes were detected in 12 untreated patients,30 recovered patients and 13 normal controls respectively from April 2010 to December 2010 in our hospital.NK cells activating receptors(NKG2D and NKp46),pofforin and granzyme-β of patients and normal controls were also detected.The correlation between these changes and hematopoietic functions,including the percentages of neutrophil granulocyte(ANC%),lymphocyte and reticulocyte absolute value in peripheral blood,and hyperplasia degree,percentage of granulocytes,erythrocytes,lymphocytes and megakaryocytes absolute value in bone marrow were evaluated.Results (1)The percentages of NK cells (10.30% ± 6.08%)and CD56 bright cells(0.11%)in untreated patients were significantly lower than those of recovered patients(16.47% ± 8.29%,0.68%,both P 〈0.05)or normal controls(19.45% ±6.88%,0.53%,both P 〈0.05).The percentage of CD56^dim cells in untreated patients was significantly lower than that of normal controls(9.62% ±6.04% vs 18.21% ±7.16%,P 〈0.05).The percentage of CD3 CD56 CD16 + cells was significantly higher in recovered patients than that of untreated patients or normal controls(0.79% vs 0.37%,0.41%,both P〈0.05).(2)The expression of NKp46 and pefforin of NK cells in untreated(88.23%,64.97% ± 21.61%)and recovered patients(82.97%,66.14% ±20.73%)were significantly higher than those of healthy controls(40.99%,42.11% ±27.25%,all P 〈0.05).(3)The percentage of NK CD56^bright and CD3^-CD56^-CD16^+ cells of patients was positively correlated with ANC%(r=0.423,0.609,0.468 respectively,all P〈0.05)and the percentage of granulocytes in bone marrow(r=0.357,0.517,0.434 respectively,all P〈0.05).The percentages of NK,CD56bight,CD56^dim and CD3^-CD56^-CD16^+ cells were positively correlated with the hyperplasic degree of bone marrow(r=0.455,0.412,0.404,0.451 respectively,all P〈0.05),but they were negatively correlated with the percentage of lymphocytes in bone marrow(r =-0.522,-0.435,-0.411,-0.547 respectively,all P 〈0.05).The expression of NKG2D,NKp46,pefforin and granzyme-β of NK cells had no correlation with hematopoiesis(all P〉0.05).Conclusion The lowered percentage of NK CD56^bright,CD56^dim cells and a higher expression of pefforin may cause the over-function of T lymphocytes and thus lead to hematopoietic failure in SAA.
出处
《中华医学杂志》
CAS
CSCD
北大核心
2011年第16期1084-1087,共4页
National Medical Journal of China
基金
国家自然科学基金(30971286、30971285)
高等学校博士学科点专项科研基金(200800620004)
卫生部卫生行业科研专项(201002024)
天津市自然科学基金(09JCYBJC11200)
天津市卫生行业科技攻关项目(11KG135)